Compare GNLX & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNLX | RFM |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.4M | 79.7M |
| IPO Year | 2022 | 2019 |
| Metric | GNLX | RFM |
|---|---|---|
| Price | $1.99 | $13.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.83 | N/A |
| AVG Volume (30 Days) | ★ 439.5K | 23.5K |
| Earning Date | 11-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.86 | $12.52 |
| 52 Week High | $6.26 | $15.03 |
| Indicator | GNLX | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 59.25 |
| Support Level | $1.86 | $13.23 |
| Resistance Level | $2.82 | $14.74 |
| Average True Range (ATR) | 0.23 | 0.21 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 21.97 | 75.37 |
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.